SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFS14A - Definitive proxy statement for special meeting:
SEC Accession No. 0000950135-97-005182
Filing Date
1997-12-24
Accepted
1997-12-24 00:00:00
Documents
1
Period of Report
1998-01-26
SROs
NASD

Document Format Files

Seq Description Document Type Size
1 GENOME THERAPEUTICS DEFS14A 105316
  Complete submission text file 0000950135-97-005182.txt   106848
Mailing Address 100 BEAVER STREET WALTHAM MA 02154
Business Address 1OO BEAVER ST WALTHAM MA 02154 6178935007
GENOME THERAPEUTICS CORP (Filer) CIK: 0000356830 (see all company filings)

IRS No.: 042297484 | State of Incorp.: MA | Fiscal Year End: 0831
Type: DEFS14A | Act: 34 | File No.: 000-10824 | Film No.: 97744203
SIC: 2835 In Vitro & In Vivo Diagnostic Substances